ICON Early Phase Services
San Antonio, Texas, United States
Non-profit organization in San Antonio, Texas
8307 Gault Ln, San Antonio, TX 78209
About ICON Early Phase Services
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Celgene
2
Proteostasis Therapeutics, Inc.
2
Regulus Therapeutics Inc.
2
Amgen
1
Emalex Biosciences Inc.
1
Ology Bioservices
1
PTC Therapeutics
1
Reven Pharmaceuticals, Inc.
1
SAb Biotherapeutics, Inc.
1
Samus Therapeutics, Inc.
1
Clinical Trials at ICON Early Phase Services
During the past decade, ICON Early Phase Services conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on
average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers
2015-06-01
2015-08-01
Completed
45
Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis
2017-04-10
2020-02-27
Completed
171
Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
2017-07-17
2019-12-23
Completed
179
Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate
2018-07-11
2018-09-12
Completed
54
A Safety and Tolerability Study of RJX Drug Product in Healthy Participants
2018-08-24
2019-01-15
Completed
76
A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects
2019-06-24
2019-12-23
Terminated
40
A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole
2019-08-28
2020-02-27
Completed
44
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ICON Early Phase Services" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Celgene" with 2 trials
sponsored, "Proteostasis Therapeutics, Inc." with 2 trials sponsored, "Regulus Therapeutics Inc." with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ICON Early Phase Services"
#1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "ERT: Clinical Trial Technology Solutions" with 1 trials as a collaborator, "ICON Development Solutions" with 1 trials as a collaborator, "ICON Early Phase Services" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at ICON Early Phase Services
According to Clinical.Site data, the most researched conditions in "ICON Early Phase Services" are
"Healthy Volunteers" (5 trials), "Healthy" (4 trials), "Overweight" (2 trials), "Alzheimer's Disease" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "ICON Early Phase Services" in a lesser frequency.
Clinical Trials Intervention Types at ICON Early Phase Services
Most popular intervention types in "ICON Early Phase Services" are "Drug" (16 trials), "Biological" (1 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "PTI-801" (2 trials), "PTI-808" (2 trials), "CC-11050" (1 trials) and "Cohort 1 Probe Substrate Cocktail" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ICON Early Phase Services
The vast majority of trials in "ICON Early Phase Services" are
17 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at ICON Early Phase Services
Currently, there are NaN active trials in "ICON Early Phase Services".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in ICON Early Phase Services,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ICON Early Phase Services, 17 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".